4.5 Article

Levels of nasal exhaled hydrogen sulfide in the general population and allergic rhinitis patients

Journal

JOURNAL OF CLINICAL LABORATORY ANALYSIS
Volume 35, Issue 3, Pages -

Publisher

WILEY
DOI: 10.1002/jcla.23678

Keywords

allergic rhinitis; biomarker; diagnosis; gas signal messenger; nasal exhaled hydrogen sulfide; persistence; severity

Funding

  1. Municipal Fund of Shenmu [2019-5]
  2. Natural Sciences Foundation of Beijing [7172179]

Ask authors/readers for more resources

This study evaluated the application value of nasal exhaled hydrogen sulfide (NeH2S) measurement in the diagnosis and assessment of allergic rhinitis (AR). Results showed that the NeH2S levels in AR patients were lower compared to the general population, indicating a potential for using NeH2S as a biomarker in AR diagnosis and severity assessment. Further studies with larger sample sizes are needed to clarify the relationship between NeH2S level and AR.
Background Objective measures used for the differential diagnosis and severity assessment of allergic rhinitis (AR) are still lacking. The involvement of hydrogen sulfide (H2S) in the development of AR indicates that nasal exhaled H2S (NeH2S) has potential as a biomarker to be used in AR patients. This study aimed to evaluate the application value of NeH2S measurement in the diagnosis and assessment of AR. Methods This study was a multi-center cross-sectional survey conducted in Northwestern China. Demographic information collection and rhinitis assessment were completed through questionnaires. The level of NeH2S and serum immunoglobulin E were measured. Results The level of NeH2S in general population ranged from 0 to 35 ppb, with a median value of 2 ppb. The NeH2S levels in seasonal allergic rhinitis (SAR) patients were significantly lower than those in general population (2 [1, 2.75] vs. 2 [2, 3] ppb; p = .023), and the NeH2S value of the SAR group tended to be lower than that of the non-allergic rhinitis (NAR) group (2 [1, 2.75] vs. 2 [2, 3] ppb; p = .094). The subgroup of AR patients with symptoms lasting longer than 2 weeks per month had a lower NeH2S level compared with the subgroup of patients with symptoms lasting less than 2 weeks per month (2 [1, 2] vs. 2 [2, 3] ppb; p = .015). Conclusion This study described the distribution range of NeH2S levels in the general population. Further study with larger sample size was needed to clarify the relationship between NeH2S level and AR.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available